Client News

Mallia to Present sCD83’s Potential for Supporting Hair Transplantation at the FUE Europe Meeting in Madrid

Horus Pharma Becomes Additional Commercialization Partner for Formycon’s Eylea® Biosimilar FYB203 in Selected European Countries under the Brand Name Baiama®

Newron Presents H1 2025 Results and Provides Business Update  

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Lindis Blood Care Announces Publication of Final Results from Pivotal REMOVE Study with CATUVAB® in the Journal of Clinical Anesthesia

Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review

InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement

Progress in Clinical Development for Alzheimer´s and Other Indications: Galimedix Therapeutics Successfully Completes Phase 1 Study With Oral Small Molecule, GAL-101, an Amyloid Beta Aggregation Modulator

AFYREN Announces its 2025 Half-Year Financial Results

ARTCLINE Announces Closing of €5 Million Financing